Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -.--% |
2019 | Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc. | CI |
2018 | PhaseRx, Inc. Bankruptcy Case Dismissed | CI |
Sales 2015 | 375K 31.28M | Sales 2016 | - | Capitalization | 18.12M 1.51B |
---|---|---|---|---|---|
Net income 2015 | -7M -584M | Net income 2016 | -20M -1.67B | EV / Sales 2015 * | - |
Net Debt 2015 | 16.55M 1.38B | Net cash position 2016 | 9.78M 816M | EV / Sales 2016 | - |
P/E ratio 2015 * |
-
| P/E ratio 2016 |
-0.58
x | Employees | 10 |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.34K | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- PZRXQ Stock